Hoppa till innehåll
  • Home
  • About us
    • Team
    • Board of Directors 
  • Our product
    • EMP16
    • Clinical Program
  • Publications
  • News & Media
    • Media
    • Press Releases
    • Blog
  • Contact
  • Home
  • About us
    • Team
    • Board of Directors 
  • Our product
    • EMP16
    • Clinical Program
  • Publications
  • News & Media
    • Media
    • Press Releases
    • Blog
  • Contact

Blog

  • Home
  • Blog
Blog
A short overview of the chronic disease obesity

Empros Pharma was founded in 2013 by researchers and entrepreneurs at Uppsala University together with the investor Flerie Invest. The company is developing EMP16, a pharmaceutical weight management treatment, planned to be ready for launch in 2027. 

Pages

  • Home
  • About us
    • Team
    • Board of Directors 
  • Our product
    • EMP16
    • Clinical Program
  • News & Media
    • Media
    • Press Releases
    • Blog
  • Contact
  • Home
  • About us
    • Team
    • Board of Directors 
  • Our product
    • EMP16
    • Clinical Program
  • News & Media
    • Media
    • Press Releases
    • Blog
  • Contact

Contact

  • info@emprospharma.com
  • Nanna Svartz väg 4, 171 65, Solna
Linkedin
© 2025 empros pharma

Hemsidan är byggd av Weblab